List of works - Marc Suárez-Calvet

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

scientific article published on 22 April 2020

Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production

scientific article published on 24 October 2013

Blood pressure is not associated with haematoma enlargement in acute intracerebral haemorrhage.

scientific article published on 20 August 2008

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

scholarly article by Marc Suárez-Calvet et al published December 2018 in EMBO Molecular Medicine

Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease

scientific article

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia

scientific article published on 20 September 2013

Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia.

scientific article published on 21 May 2013

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

scientific article published in March 2011

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

scientific article published on 26 October 2020

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease

scientific article published on 6 December 2012

Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion

scientific article published on 8 September 2014

Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury

scientific article published on December 2016

Endothelial progenitor cells in acute ischemic stroke.

scientific article published on 22 September 2013

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia.

scientific article published on 11 April 2012

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation

scientific article published on 10 August 2020

Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis

scientific article

Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease

scientific article published on 01 August 2019

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease

scientific article published on 15 February 2018

Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.

scientific article published on 19 February 2016

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected

scientific article published on 10 November 2020

Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals

scientific article published on 05 July 2019

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

scientific article published on 28 November 2019

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

scientific article published on 4 December 2013

Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease

scientific article published on 11 October 2012

Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease

scholarly article by Alix de Calignon et al published October 2012 in Neuron

Propagation of tau pathology in a model of early Alzheimer's disease

scientific article (publication date: 23 February 2012)

Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease

scientific article published in January 2014

Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease

scientific article published on August 2013

Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort

scientific article published on 24 January 2019

Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis

scientific article published on 18 June 2011

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

scientific article

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy

scientific article

Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

scientific article published on December 2010

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.

scientific article

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease

scientific article published on 21 March 2019

The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.

scientific article published on 30 May 2017

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

scientific article published on 01 August 2019

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease

article by Miguel Ángel Araque Caballero et al published 1 October 2018 in Brain

White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants

scientific article published on 28 November 2019

ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer

scientific article published on 21 July 2008

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers

scientific article

List of works by Marc Suárez-Calvet

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production

Blood pressure is not associated with haematoma enlargement in acute intracerebral haemorrhage.

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline

Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia

Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia.

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease

Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion

Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury

Endothelial progenitor cells in acute ischemic stroke.

Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia.

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation

Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis

Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease

Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected

Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation

Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease

Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease

Propagation of tau pathology in a model of early Alzheimer's disease

Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease

Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease

Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort

Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: results from a case-control study and a meta-analysis

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy

Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease

The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease

White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants

ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers